Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer

Maintenance pemetrexed offers survival benefit with well-tolerated toxicities for advanced non-squamous non-small cell lung cancer (NSCLC). We present 3 consecutively enrolled patients with advanced non-squamous NSCLC, receiving stereotactic ablative radiotherapy (SABR) for oligoprogressive disease...

Full description

Bibliographic Details
Main Authors: Shao-Lun Lu, Feng-Ming Hsu, Kuan-Yu Chen, Chao-Chi Ho, James Chih-Hsin  Yang, Jason Chia-Hsien Cheng
Format: Article
Language:English
Published: Karger Publishers 2016-08-01
Series:Case Reports in Oncology
Subjects:
Maintenance pemetrexed
Oligoprogression
Stereotactic ablative radiotherapy
Online Access:http://www.karger.com/Article/FullText/448804

Internet

http://www.karger.com/Article/FullText/448804

Similar Items